Bharat Biotech Unveils New Brand Identity
Vaccine maker Bharat Biotech has unveiled its new corporate logo and vision for the future. With its new logo and tag line ‘Lead Innovation’, the Hyderabad-based company is underlining its focus for developing new made-in-India molecules to prevent neglected diseases that affect a large populace in the developing world.
This new logo launch coincides with Bharat Biotech’s 20 years of operations. To mark the occasion, it had committed to contribute Rs. 1-crore worth of vaccines to the Telangana government for its public health immunisation. “This year has been a double treat for the Bharat Biotech family, with our two pathbreaking vaccines Typbar TCV and Rotavac, getting global recognition and endorsement from the World Health Organisation (WHO). These developments reinforce our foundation for the next stage of growth,” Dr. Krishna Ella, Chairman and Managing Director, said in a release.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Dangers Of Vaccines That Commenly Used
-
An Insight Into The Vaccine Causing Blood Clots
-
Overview Of The Top 5 Vaccine Companies In China
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
Analysis of the biggest producer of vaccines on coronavirus in China
-
6 Drugs Sold For Nearly $120 Billion
-
Two inactivated vaccines against COVID-19 start clinical trials
-
Bill Gates is funding factories for 7 potential coronavirus vaccines
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Turkey’s BOTAS Expands LNG Supply Portfolio at Gastech 2025
Recommend Reading
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Mitsui, Idemitsu, and Sumitomo Restructure Polyolefins Business
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
NextDecade Approves FID for Fourth LNG Train at Rio Grande Project
-
Recent EVA Market Trends Continue to Rise in China
-
Geopolitical Expectations Reversal Drags Down Crude Oil, Wednesday's Plunge Exceeds 5%
-
Methylene Chloride Market Hits Bottom and Stabilizes, with Supply Contraction Driving a Moderate Recovery
-
Supply Shortage Supports Strong Performance in Chinese Metallurgical Coke Market
-
Supply Tightening Dominates the Market, Acrylic Acid Prices Steady with an Uptick